D. Bilton (London, United Kingdom), M. Vendrell Relat (Girona, Spain)
Late Breaking Abstract: Outcome of ventilator associated pneumonia according to different pseudomonas aeruginosa serotypes
M. Tamm, V. Gafner, H. Lazar, E. Mus, A. Perez, on Behalf of P.A. Serotype Group (Basel, Berne, Switzerland)
|  |
Time to diagnosis and adherence to guidelines in a large cohort of patients with non-CF bronchiectasis
J. Altenburg, W. G. Boersma (Alkmaar, Netherlands)
| |
Characteristics of PCP PCR positive non HIV immunocompromised patients
S. Chandramouli, H. Shoo, S. Huq, N. Duffy (Liverpool, United Kingdom)
|  |
The prognostic factor of lung abscess
K. Ando, Y. Ohkuni, R. Matsunuma, K. Nakashima, T. Iwasaki, N. Asai, D. Yasui, M. Misawa, N. Kaneko (Kamogawa, Japan)
| |
The relationship between Mycobacterium avium complex infection and aspergillus lung disease in bronchiectasis
Z. Zoumot, R. Wilson (London, United Kingdom)
| |
Correlation between the high resolution computed tomography scoring and lung functions in patients of stable bronchiectasis
K. B. Gupta, S. Vishvkarma, S. Magu, U. Choudhary, P. P. Gupta, R. S. Shandilya (Rohtak, India)
| |
Sputum neutrophils are related to functional status in non-cystic fibrosis bronchiectasis
F. L. Dente, A. Di Franco, M. L. Bartoli, M. Carli, F. Piera, P. L. Paggiaro (Pisa, Italy)
| |
MAPKAP Kinase 2-deficient mice show increased susceptibility to Pseudomonas aeruginosa infection
T. Kerber-Momot, A. Munder, A. Kotlyarov, M. Gaestel, T. Tschernig, M. Ochs (Hannover, Germany)
| |
Inpatient management of non-CF bronchiectasis: Should patients be managed as in CF?
A. James, A. Wood, J. Whitehouse (Birmingham, United Kingdom)
| |
Air flow obstruction is associated with Pseudomonas in non-CF bronchiectasis patients
S. Zaidi, K. Khan, R. Behan, E. Moloney, S. Lane (Dublin, Ireland)
| |
The effect on imipenem on the regulation of ampC and oprD genes in Pseudomonas biofilm
H. Jiang, L. Wang (Qingdao, China)
| |
CHANGES IN SUSCEPTIBILITY TO ANTIBIOTICS PSEUDOMONAS AERUGENOSA UNDER EFFECT OF DISSOLVED OZONE
I. Belyanin, A. Plotnikova (Moscow, Russian Federation)
| |
Respiratory viral infections in Iranian patients with exacerbation of chronic obstructive pulmonary disease
S. S. Hosseini, R. Tamadon, R. Yaghoobi, H. Jamaati, S. A. Nadji (Jahrom, Tehran, Islamic Republic Of Iran)
| |
Health status measured using ‘CAT‘ in bronchiectasis relates to disease severity
L. Ozerovitch, A. Shoemark, L. Pigram, A. Devaraj, M. Meister, D. Hansell, R. Wilson (London, United Kingdom)
| |
Similarities and differences between patients with chronic obstructive pulmonary disease and/or bronchiectasis
I. A. Paschoal, J. R. Gonçalves, M. C. Pereira, E. M. Figueiras Pedreira de Cerqueira, D. O. Magro (Sumaré, Brazil)
| |
Presence of fungus in sputum of patients treated with antibiotics or inhaled steroids
T. Sahasrabudhe, P. Sinha, N. Gandham, S. Garg (Pune, India)
| |
Qualitative analysis of bacterial contamination of inhaler devices
A. Boyter, F. Mabbott, A. Smith, A. Mullen (Glasgow, United Kingdom)
| |
Retrospective analysis of pulmonary manifestations and death due to aspiration in patients submitted for CVA
L. Oswald, W. Boersma (Netherlands)
| |
Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia
S. Hanada, H. Uruga, H. Takaya, A. Miyamoto, H. Sugimoto, N. Morokawa, A. Korosaki, T. Fujii, K. Kishi (Tokyo, Japan)
| |